1
Clinical Trials associated with Bisoctrizole/Titanium dioxideEvaluation of the Protection Activity of Microfine Ti02, Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With SU: Phase II Photoprovocation Test
Commercially available external photoprotectors (EP) do not provide adequate protection against ultraviolet A (UVA) and visible wavelengths. The proposed medicinal product V0096 CR (formula RV3131A-MV1166) is a broad spectrum EP (bsEP). The rationale for the use of V0096 CR (formula RV3131A-MV1166) in the proposed condition is based on its ability to broadly block the UVA radiations and visible light that are known to trigger solar urticaria (SU).
100 Clinical Results associated with Bisoctrizole/Titanium dioxide
100 Translational Medicine associated with Bisoctrizole/Titanium dioxide
100 Patents (Medical) associated with Bisoctrizole/Titanium dioxide
100 Deals associated with Bisoctrizole/Titanium dioxide